BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Health Care Journalists - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Association of Health Care Journalists
X-ORIGINAL-URL:https://healthjournalism.org
X-WR-CALDESC:Events for Association of Health Care Journalists
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250213T140000
DTEND;TZID=America/New_York:20250213T150000
DTSTAMP:20260411T211238
CREATED:20250128T204528Z
LAST-MODIFIED:20250213T224626Z
UID:58252-1739455200-1739458800@healthjournalism.org
SUMMARY:Unraveling the myth: ProPublica's investigation into a bad doc and a reckless hospital
DESCRIPTION:The infamous “Dr. Death” case in Texas showed just how little oversight there often is of physicians. When confronted with a neurosurgeon who was maiming and killing patients\, multiple hospitals looked the other way. Meanwhile\, the state medical board dragged its feet in taking punitive action\, and Texas malpractice law discouraged private lawsuits. \n\n\n\nNow\, ProPublica reporter Dave McSwane has investigated yet another shocking case of prolonged physician misconduct — this time in a very different setting. Montana oncologist Thomas Weiner\, who was beloved by his patients and their families as well as his staff\, now stands accused of numerous legal and ethical breaches that harmed and killed patients. \n\n\n\nAmong the infractions: treating patients for cancers they didn’t actually have\, changing end-of-life care directives without patient consent\, and improperly prescribing narcotics. In this webinar\, McSwane will talk about what he’s learned about why\, in this case\, hospital officials and fellow physicians remained silent about their suspicions that Weiner was harming patients\, and why federal regulators and health plans failed to step in to stop the abuses. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n\nMary Chris Jaklevic\n\n\n\nAHCJ Health Beat Leader for Patient SafetyMary Chris Jaklevic is AHCJ’s health beat leader for patient safety based in Chicago. She’s an independent journalist who has covered health care finance\, clinical care and medical research for a variety of professional and consumer publications. Her interest in patient safety issues and the potential harms of medical interventions was honed by her experience as a contributor to HealthNewsReview.org\, a project that aimed to improve health care journalism by critiquing the accuracy and balance of media messages about medical treatments and tests. She’s a longtime AHCJ member and served on the board for two terms. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJ. David McSwane\n\n\n\nReporter\, ProPublicaJ. David McSwane is a reporter in ProPublica’s Washington\, D.C.\, office. Previously\, he was an investigative reporter for the Dallas Morning News\, where his reporting on the state’s outsourced Medicaid system\, which benefited companies that systematically deny care to sick children and disabled adults\, spurred multiple legislative reforms. Before that he wrote for the Austin American-Statesman and a small Florida newspaper. McSwane’s reporting has spurred new laws and state and federal criminal investigations\, forced belt-tightening lawmakers to invest in social programs and won some trinkets along the way\, including Harvard’s Goldsmith Prize for Investigative Reporting\, the Worth Bingham Prize\, a Scripps Howard award\, an IRE award and the Peabody. He’s a four-time Livingston Award finalist.
URL:https://healthjournalism.org/unraveling-the-myth-propublicas-investigation-into-a-bad-doc-and-a-reckless-hospital/
CATEGORIES:Patient Safety,Webinar
ATTACH;FMTTYPE=image/png:https://healthjournalism.org/wp-content/uploads/2025/01/Propublica-investigation-feb-13-webinar-featured-img.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250219T130000
DTEND;TZID=America/New_York:20250219T140000
DTSTAMP:20260411T211238
CREATED:20250210T184709Z
LAST-MODIFIED:20250220T161517Z
UID:58509-1739970000-1739973600@healthjournalism.org
SUMMARY:Decentralized: Navigating the future of inclusive clinical trials
DESCRIPTION:Decentralized clinical trials have emerged as a promising approach to overcome traditional barriers\, enhance representation\, and improve the quality of research by bringing biomedical studies directly into communities. However\, recent policy changes under the Trump administration\, including the removal of FDA guidance on clinical trial diversity\, have raised concerns about the future of inclusive research. \n\n\n\nRead more about decentralizing clinical trials here. \n\n\n\nIn this webinar\, Ray Dorsey\, M.D.\, professor of neurology and the director of the Center for Human Experimental Therapeutics at the University of Rochester Medical Center in New York\, and Ramita Tandon\, Chief Clinical Trials Officer at Walgreens\, will discuss how decentralization is reshaping clinical research. They will explore the potential of pharmacy-based trials and strategies for increasing patient engagement. \n\n\n\nJoin us for an insightful conversation on the future of clinical trials and what it means for patients\, researchers\, and the healthcare industry. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n\nJyoti Madhusoodanan\n\n\n\nAHCJ Civic Science FellowJyoti Madhusoodanan is AHCJ’s Civic Science Fellow\, covering race in health algorithms as part of a year-long fellowship funded by the Doris Duke Foundation. She is an independent science and health journalist who regularly covers biomedical research\, health equity\, clinical trials\, and the translation of basic research into clinical care. Her reporting on race adjustments in clinical algorithms was supported by a 2020 project fellowship from the MIT Knight Science Journalism program; reporting on other topics has received fellowship support from the Alicia Patterson Foundation\, the GSA Journalists in Aging program\, and others. Madhusoodanan is a senior contributor to Undark magazine and her work regularly appears in Nature\, Scientific American\, and other outlets. She also serves on the Board of Directors of the National Association of Science Writers. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n\nLara Salahi\n\n\n\nAHCJ Health Equity Beat LeaderLara Salahi is AHCJ’s health beat leader on health equity. She’s an award-winning\, independent health journalist based in Boston\, whose work has appeared in local\, national and international television and digital news outlets. She is also the Distinguished Professor of Journalism at Endicott College in Beverley\, Mass. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRay Dorsey\, M.D.\n\n\n\nProfessor of Neurology\, University of RochesterRay Dorsey\, M.D.\, is the David M. Levy Professor of Neurology at the University of Rochester and one of the world’s most read\, cited\, and followed neurologists. With his colleagues\, he wrote “Ending Parkinson’s Disease: A Prescription for Action\,” a book that provides a prescription for preventing and ending the world’s fastest growing brain disease. \n\n\n\nDorsey previously directed the University of Rochester’s Center for Health + Technology\, was elected chair of the international Huntington Study Group\, led the movement disorders division and neurology telemedicine at Johns Hopkins\, and consulted for McKinsey & Company. He completed his undergraduate degree at Stanford University and pursued his medical education and neurology training at the University of Pennsylvania where he also earned an MBA in healthcare management from the Wharton School. \n\n\n\nIn 2015\, the White House recognized Dorsey as a “Champion for Change” for Parkinson’s disease. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRamita Tandon\n\n\n\nChief BioPharma Services Officer\, WalgreensAs Chief BioPharma Services Officer at Walgreens\, Ramita Tandon is responsible for leading and driving growth for the Company’s biopharma services\, which includes Walgreens Clinical Trials. In her role\, Ramita works across the healthcare and life sciences industries to enable next-generation clinical trials\, with the goal of making treatments equitable and accessible to patients. \n\n\n\nRamita brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses in real-world evidence and patient-centered health outcomes. Since spearheading the launch of Walgreens Clinical Trials in June 2022\, Ramita and her team have been working to make clinical research an inherent care option for patients across the nation when the standard of therapy is not a viable option.  \n\n\n\nThrough its tailored efforts and collaboration with biopharma companies\, Ramita and her team have connected with more than 17 million people for potential recruitment into a sponsor-led clinical trial\, with that number growing daily. Research shows that only 5% of the U.S. population participates in clinical trials and nearly 80% of trials fail to meet their enrollment goals in the timeline presented\, which often contributes to delays in getting novel therapies to patients.  \n\n\n\nUltimately\, Ramita and her team’s main goal is to bring community pharmacy-led clinical trials to patients quicker by meeting them where they want to be met…in their own communities.
URL:https://healthjournalism.org/decentralized-navigating-the-future-of-inclusive-clinical-trials/
CATEGORIES:Algorithms and Health Disparities,Event,Health Equity,Webinar
ATTACH;FMTTYPE=image/png:https://healthjournalism.org/wp-content/uploads/2025/02/Decentralized-clinical-trials-webinar-ad.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250221T120000
DTEND;TZID=America/New_York:20250221T130000
DTSTAMP:20260411T211238
CREATED:20250131T202324Z
LAST-MODIFIED:20250221T210049Z
UID:58347-1740139200-1740142800@healthjournalism.org
SUMMARY:Reporting on the crucial role doctors play in gun violence prevention
DESCRIPTION:Gun suicides reached an all-time high in 2023\, and almost 4% of gun-related deaths in the United States were unintentional shootings — the worst year on record for unintentional shootings by children.  \n\n\n\nAt the same time\, firearms are used in more than three out of five intimate partner homicides in the United States. Yet more than half of clinicians report that they avoid discussing firearm access and safety with patients because they don’t feel equipped to do so or worry about alienating their patients.  \n\n\n\nIn this webinar\, trauma surgeon Dr. Joseph Sakran will talk about how the medical community must overcome its reticence\, take responsibility and prepare to have these difficult conversations.  \n\n\n\nHe’ll talk through a new resource guide from the gun violence prevention organization Brady United that helps clinicians talk to their patients about firearm access and safety. He will also share how health care journalists can cover firearm access and highlight story ideas. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n\nKaitlin Washburn\n\n\n\nAHCJ Health Beat Leader for Firearm ViolenceKaitlin Washburn is AHCJ’s health beat leader for firearm violence and trauma and an independent journalist based in Chicago\, primarily working for the Chicago Sun-Times. She was a gun violence reporter for two years in Missouri for The Kansas City Star as a Report for America corps member. Previously\, Washburn was an agriculture reporter covering the omnipresent industry in California’s Central Valley for The Sun-Gazette\, also as a part of RFA. Previously\, Washburn had internships at the Morning Call in Pennsylvania\, the Center for Responsive Politics in Washington\, D.C. and The Oregonian in Portland. She spent three years as a researcher for Investigative Reporters and Editors\, based at The University of Missouri. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJoseph Sakran\, M.D.\n\n\n\nBoard Chair and Chief Medical Officer\, Brady UnitedTrauma surgeon\, Johns HopkinsAn award-winning researcher and pioneer in promoting firearm injury prevention\, Dr. Sakran’s dedication to his field is rooted in his lived experience of trauma from gun violence.  \n\n\n\nAt the age of 17\, Dr. Sakran was nearly killed after being shot in the throat with a 38-caliber bullet after a high school football game. \n\n\n\nAn active leader at the Johns Hopkins Hospital in Baltimore\, Dr. Sakran serves as the executive vice chair of Surgery\, director of Clinical Operations for Surgery\, and associate professor of Surgery and Nursing. His public health research — specifically on firearm injury prevention — has been recognized by the Agency for Healthcare Research and Quality (AHRQ) and Academy Health. \n\n\n\nDr. Sakran gained international prominence in 2018 when the NRA told doctors concerned about gun violence to “stay in their lane” and avoid addressing the topic. Dr. Sakran spoke out to illustrate that healthcare professionals are on the frontlines of this epidemic. In response\, Dr. Sakran launched @ThisIsOurLane\, a grassroots movement of medical professionals committed to reducing firearm injuries and deaths.
URL:https://healthjournalism.org/reporting-on-the-crucial-role-doctors-play-in-gun-violence-prevention/
CATEGORIES:Firearm Violence,Webinar
ATTACH;FMTTYPE=image/png:https://healthjournalism.org/wp-content/uploads/2025/01/Reporting-on-the-crucial-role-doctors-play-in-gun-violence-prevention-webinar-img.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250226T130000
DTEND;TZID=America/New_York:20250226T140000
DTSTAMP:20260411T211238
CREATED:20250130T182023Z
LAST-MODIFIED:20250226T200532Z
UID:58316-1740574800-1740578400@healthjournalism.org
SUMMARY:How research misconduct harms patients and science
DESCRIPTION:Fraud\, manipulation and research misconduct can lead scientists down a slippery slope\, affecting drug development\, grant funding\, and patients’ lives. Scientists working in the field of Alzheimer’s research are under enormous pressure to maintain grant funding\, publish\, and\, ultimately\, find a cure. For decades\, their primary focus has been preventing or eliminating amyloid plaque in the brain\, an approach that builds on prior research discoveries. We’re now learning that decades of research may have been misguided\, or even fraudulent. \n\n\n\nCharles Piller\, an investigative journalist for Science and author of “Doctored: Fraud\, Arrogance\, and Tragedy in the Quest to Cure Alzheimer’s\,” has reported on clear signs of manipulated images by a top National Institute of Aging scientist\, found multiple examples of deception by other Alzheimer’s researchers\, and exposed questionable behavior by FDA officials about who had a role in Alzheimer’s drug development and approvals.  \n\n\n\nPiller collaborated with Matthew Schrag\, M.D.\, Ph.D.\, a top neuroscientist at Vanderbilt University\, who first spotted these instances of data manipulation. Piller’s reporting was a wake-up call for many in the scientific community\, including at the National Institutes of Health. \n\n\n\nIn this webinar\, Piller and Schrag will discuss what they uncovered\, how the situation spiraled\, how to spot red flags on questionable papers\, and what journalists should know about the future of Alzheimer’s research. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nModerator\n\n\n\n\nLiz Seegert\n\n\n\nAHCJ Health Beat Leader for AgingLiz Seegert is AHCJ’s health beat leader on aging. She’s an award-winning\, independent health journalist based in New York’s Hudson Valley\, who writes about caregiving\, dementia\, access to care\, nursing homes and policy. Seegert is also a contributing writer for Fortune.com\, the American Journal of Nursing\, and PBS/NextAvenue.org\, reporting on myriad health topics\, including social determinants of health and women’s health. She has written for TIME Health\, The Wirecutter\, Money.com\, Medscape\, Consumer Reports\, The Guardian and Medical Economics\, as well as dozens of other trade and mainstream media. Her articles have been syndicated in Forbes.com\, the Los Angeles Times\, the Hartford Courant\, The Saturday Evening Post and other major outlets. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharles Piller\n\n\n\nInvestigative journalist\, ScienceCharles Piller is an investigative journalist for Science magazine whose work has appeared in the Los Angeles Times\, the New York Times\, the Sacramento Bee\, and other publications. Piller has been honored with many national journalism awards and is the co-author of “Gene Wars: Military Control over the New Genetic Technologies” and the author of “The Fail-Safe Society: Community Defiance And The End Of American Technological Optimism” and “Doctored: Fraud\, Arrogance\, and Tragedy in the Quest to Cure Alzheimer’s.” He has reported on public health\, biological warfare\, infectious disease outbreaks\, and other topics from the United States\, Africa\, Asia\, Europe\, and Central America. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMatthew Schrag\, M.D.\, Ph.D.\n\n\n\nAssistant professor of neurology\, Vanderbilt University Medical CenterMatthew Schrag\, M.D.\, Ph.D.\, is an assistant professor of neurology at Vanderbilt University Medical Center and a principal investigator at Schrag Lab\, who studies the overlap between vascular and cognitive neurological diseases. His research focuses on the mechanisms of vascular degeneration in cerebral amyloid angiopathy and how this contributes to cognitive impairment in Alzheimer’s disease.  \n\n\n\nDr. Schrag’s investigative work is independent of his job at Vanderbilt University Medical Center and is not speaking on behalf of the university for this webinar.
URL:https://healthjournalism.org/how-research-misconduct-harms-patients-and-science/
CATEGORIES:Aging,Medical Studies,Webinar
ATTACH;FMTTYPE=image/png:https://healthjournalism.org/wp-content/uploads/2025/01/How-research-misconduct-harms-patients-and-science-webinar-featured-img.png
END:VEVENT
END:VCALENDAR